Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
5861
-
5862
-
5863
-
5864
-
5865
-
5866
-
5867
-
5868
-
5869
-
5870
-
5871
-
5872
-
5873
-
5874
-
5875
Molecular Insights on Methane Hydrate Dissociation in the Presence/Absence of Poly-<i>N-</i>vinylcaprolactam: Effects of Gas Saturation and Nanobubbles
Published 2025“…For the systems with PVCap, it was found that PVCap has a certain promoting effect on methane hydrate dissociation; the promotion effect decreased with the increase in methane content in the initial liquid phase. …”
-
5876
Molecular Insights on Methane Hydrate Dissociation in the Presence/Absence of Poly-<i>N-</i>vinylcaprolactam: Effects of Gas Saturation and Nanobubbles
Published 2025“…For the systems with PVCap, it was found that PVCap has a certain promoting effect on methane hydrate dissociation; the promotion effect decreased with the increase in methane content in the initial liquid phase. …”
-
5877
Molecular Insights on Methane Hydrate Dissociation in the Presence/Absence of Poly-<i>N-</i>vinylcaprolactam: Effects of Gas Saturation and Nanobubbles
Published 2025“…For the systems with PVCap, it was found that PVCap has a certain promoting effect on methane hydrate dissociation; the promotion effect decreased with the increase in methane content in the initial liquid phase. …”
-
5878
-
5879
-
5880
Imaging CDK4/6 Broaden Options of Breast Cancer Diagnostics with Positron Emission Tomography
Published 2025“…This study developed a novel PET radiotracer to screen breast cancer patients sensitive to CDK4/6 inhibitors, guiding personalized treatment. …”